Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Inspecs shares slide as interim earnings fall, H2 outlook weakens

(Sharecast News) - Shares in eyewear manufacturer Inspecs slumped nearly 10% on Thursday after it posted a drop in interim earnings and flagged weaker-than-expected trading in early H2, citing ongoing tariff disruption, subdued consumer confidence, and reduced government spending in the US.

Inspecs said revenue for the six months ended 30 June fell to £97.6m, down from £100.6m a year earlier, while underlying earnings declined to £9.0m from £11.0m. Gross margin narrowed to 51.8% from 52.6%, and diluted underlying earnings per share dropped to 2.08p from 3.94p. Pre-tax profits were broadly flat at £2.4m.

The AIM-listed group also said its Chinese manufacturing operations continued to face delays due to US tariffs, while European trading was said to have remained sluggish. Net debt excluding leases rose by £700,000 to £23.6m, driven by deferred acquisition payments and funding for discontinued operations.

However, despite the weaker start to the second half, Inspecs said growth in its order book and planned cost savings were expected to support a stronger performance in the remainder of the year. It also reiterated full-year guidance for underlying EBITDA of £18.7m.

CEO Richard Peck said: "As a global eyewear business, we have experienced first-hand the widely reported macro-challenges, including ongoing tariff disruption and subdued consumer confidence. As a result, group sales in the first half are slightly behind last year.

"Based on the growth in our order books as at the end of August 2025 and planned increased cost savings the board has a reasonable expectation of meeting full year guidance. We continue to believe in the fundamental strengths of the business and the management team remains focused on the delivery of our medium-term targets."

As of 1030 BST, Inspecs shares had sunk 9.53% to 38.90p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

RBC lifts BHP Group target price, but stays neutral on stock
(Sharecast News) - RBC Capital Markets has raised its target price for BHP Group after the mining giant's stronger-than-expected first-half results, welcoming the group's accelerating copper momentum, but kept a 'sector perform' rating on the stock.
JPMorgan places Inchcape on 'positive catalyst watch', lifts price target
(Sharecast News) - Inchcape shot higher on Wednesday after JPMorgan placed the shares on 'positive catalyst watch' ahead of full-year results on 3 March and hiked the price target to 880p from 800p.
Berenberg lowers Unilever to hold
(Sharecast News) - Analysts at Berenberg downgraded consumer goods giant Unilever from 'buy' to 'hold' on Wednesday, stating the company has, in its view, completed its transformation into "a simpler, more agile, faster-growing and more profitable business" than it was two to three years ago.
Galliford Try appointed to £15.4bn Department for Education framework
(Sharecast News) - Construction group Galliford Try said on Wednesday that its building business has been appointed to the new £15.4bn Department for Education (DfE) Construction Framework 25 (CF25).

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.